Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:
CRISPR Therapeutics (CRSP) : "This is a momentum stock and momentum is out of favor so I can't recommend this one."
Cramer and the AAP team say they like these stocks in times of volatility: Johnson & Johnson (JNJ) , Goldman Sachs (GS) and more. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
Over on Real Money, Cramer explains more why he thinks retail stocks are going to get dumped. Get more of his insights with a free trial subscription to Real Money.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.